You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨產業迎來“大利好”,中藥股集體上漲,康惠製藥漲停
格隆匯 03-21 09:39
A股市場中藥股集體上漲,其中,大唐藥業漲超19%,恩威醫藥漲超17%,*ST吉藥漲近16%,康惠製藥10CM漲停,新光藥業漲超8%,生物谷、隴神戎發漲超7%,粵萬年青漲超5%,ST百靈、歐康醫藥、葫蘆娃、上海凱寶、維康藥業、沃華醫藥、片仔癀等跟漲。消息面上,3月20日,國辦印發《關於提升中藥質量促進中醫藥產業高質量發展的意見》提到,加大中藥資源保護力度。規範珍稀中藥資源開發利用,突破一批珍稀中藥資源的繁育、仿生、替代技術。推進中藥材生態種植養殖,因地制宜發展林草中藥材。加強中藥材流通和儲備體系建設,加強中藥材市場管理,完善中藥材價格監管機制。培育名優中藥品種,加強中藥炮製技術傳承創新,支持中藥大品種創新改良。打造知名中藥品牌。積極支持符合條件的中藥企業通過發行債券等方式融資。另外,國新辦將於今日上午10點舉行國務院政策例行吹風會,介紹提升中藥質量促進中醫藥產業高質量發展有關情況。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account